Off-patent drugs make up 91% of prescriptions, but only 18% of spending - report

Investments in the pharmacological and pharmaceutical business

Roman Didkivskyi/iStock via Getty Images

Generic and biosimilar medicines represented 91% of the 6.4B prescriptions Americans received in 2021 but accounted for only about 18% of medicinal spending, the latest industry report from the trade group Association for Accessible Medicines (AAM) indicates.

Recommended For You

Comments (15)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.